Search PubMed⌕ Search

Biomedical subjects

L D Serova

Publications and source records attributed to L D Serova.

At least 37 records · Page 2Linked to original sources

[Immunocorrective therapy of destructive pancreatitis complicated by hepatic insufficiency].

Study of the immune status in 51 patients with necrotic and pyonecrotic pancreatitis complicated by hepatic insufficiency revealed an extremely severe degree of inhibition of cellular and humoral immunity. The use of Anti-lympholin, an immunocorrector of a directed action, and reinfusion of the patients' blood irradiated with ultraviolet rays causes a marked immunostimulating effect, reduces the number of pyoseptic complications, and facilitates the reduction of fatal cases among the most serious contingent of patients with acute pancreatitis.

Acute Disease↗

[Disorders of immunologic reactivity in patients with destructive pancreatitis with functional insufficiency of the liver].

Results of the investigation of immunological status in 62 patients with destructive pancreatitis complicated by hepatic insufficiency are presented. An extremely severe degree of immunodepression in the given contingent of patients was shown. It was established that the degree of inhibition of the cellular and humoral immunity in patients with destructive pancreatitis had direct relation to the degree of the functional insufficiency of the liver. A conclusion was made about the necessity to include immunocorrecting measures in the complex therapy.

Acute Disease↗

[The possibility of predicting the development of bronchial asthma].

A total of 235 patients with bronchial asthma and preasthma and their 85 relatives of the 1st degree of kinship were investigated. A detailed clinicofunctional and immunological investigation including a study of histocompatibility antigens, revealed the relationships between bronchial asthma development and antigens A2, B13, B21, B35 carriage. The authors presented a complex of methods (provocative acetylcholine tests, anaprilin test, determination of HLA antigens) permitting the prediction of this disease in patients with an aggravated hereditary and allergological history at the preclinical stage.

Adolescent↗